Cytochromes P450: Exploiting diversity and enabling application as biocatalysts

Current Opinion in Chemical Biology

Volumn 15, Issue 2, 2011, Pages 241-248

  Grogan, Gideon ^a  

^a UNIVERSITY OF YORK   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CATALASE; CYTOCHROME; CYTOCHROME P450; CYTOCHROME P450 REDUCTASE; RESORUFIN;

AMINO ACID SEQUENCE; ASPERGILLUS; ASPERGILLUS ORYZAE; BACILLUS MEGATERIUM; BIOCATALYSIS; BIOCATALYST; BIOSYNTHESIS; CHEMICAL REACTION; ENANTIOSELECTIVITY; ENZYME ACTIVITY; ENZYME ENGINEERING; ENZYME SUBSTRATE; FLUORESCENCE; GENOMICS; HYDROXYLATION; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PROTEIN EXPRESSION; REVIEW; RHODOCOCCUS; STREPTOMYCES; STREPTOMYCES COELICOLOR;

ANIMALS; BACTERIA; CYTOCHROME P-450 ENZYME SYSTEM; FUNGI; GENOMICS; HUMANS; PROTEIN ENGINEERING;

EID: 79953297687     PISSN: 13675931     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cbpa.2010.11.014     Document Type: Review

References (58)

1. Omura T. Structural diversity of cytochrome P450 enzyme system. J Biochem 2010, 147:297-306.
2. Ortiz de Montellano P.R. Hydrocarbon hydroxylation by cytochrome P450 enzymes. Chem Rev 2009, 110:932-948.
3. Julsing M.K., Cornelissen S., Bühler B., Schmid A. Heme-iron oxygenases: powerful industrial biocatalysts?. Curr Opin Chem Biol 2008, 12:177-186.
4. Torres Pazmiño D.E., Winkler M., Glieder A., Fraaije M.W. Monooxygenases as biocatalysts: classification, mechanistic aspects and biotechnological applications. J Biotechnol 2010, 146:9-24.
5. Rabe K., Gandubert V., Spengler M., Erkelenz M., Niemeyer C. Engineering and assaying of cytochrome P450 biocatalysts. Anal Bioanal Chem 2008, 392:1059-1073.
6. Gillam E.M.J. Engineering cytochrome P450 enzymes. Chem Res Toxicol 2008, 21:220-231.
7. Nelson D.R. The cytochrome P450 homepage. Hum Genomics 2009, 4:59-65.
8. Park J., Lee S., Choi J., Ahn K., Park B., Park J., Kang S., Lee Y.-H. Fungal cytochrome P450 database. BMC Genomics 2008, 9:402.
9. Furuya T., Kino K. Genome mining approach for the discovery of novel cytochrome P450 biocatalysts. Appl Microbiol Biotechnol 2010, 86:991-1002.
10. Ouellet H., Johnston J.B., Ortiz de Montellano P.R. The Mycobacterium tuberculosis cytochrome P450 system. Arch Biochem Biophys 2010, 493:82-95.
11. Capyk J.K., Kalscheuer R., Stewart G.R., Liu J., Kwon H., Zhao R., Okamoto S., Jacobs W.R., Eltis L.D., Mohn W.W. Mycobacterial cytochrome P450 125 (Cyp125) catalyzes the terminal hydroxylation of C27 steroids. J Biol Chem 2009, 284:35534-35542.
12. Rosłoniec K.Z., Wilbrink M.H., Capyk J.K., Mohn W.W., Ostendorf M., van der Geize R., Dijkhuizen L., Eltis L.D. Cytochrome P450 125 (CYP125) catalyses C26-hydroxylation to initiate sterol side-chain degradation in Rhodococcus jostii RHA1. Mol Microbiol 2009, 74:1031-1043.
13. Zhao B., Lin X., Lei L., Lamb D.C., Kelly S.L., Waterman M.R., Cane D.E. Biosynthesis of the sesquiterpene antibiotic albaflavenone in Streptomyces coelicolor A3(2). J Biol Chem 2008, 283:8183-8189.
14. Lamb D.C., Lei L., Zhao B., Yuan H., Jackson C.J., Warrilow A.G.S., Skaug T., Dyson P.J., Dawson E.S., Kelly S.L., et al. Streptomyces coelicolor A3(2) CYP102 protein, a novel fatty acid hydroxylase encoded as a heme domain without an N-terminal redox partner. Appl Environ Microbiol 2010, 76:1975-1980.
15. Cresnar B., Petric S. Cytochrome P450 enzymes in the fungal kingdom. Biochim Biophys Acta - Proteins & Proteomics 2011, 1814:29-35.
16. Nazmul Hussain Nazir K., Ichinose H., Wariishi H. Molecular characterization and isolation of cytochrome P450 genes from the filamentous fungus Aspergillus oryzae. Arch Microbiol 2010, 192:395-408.
17. Artigot M.P., Loiseau N., Laffitte J., Mas-Reguieg L., Tadrist S., Oswald I.P., Puel O. Molecular cloning and functional characterization of two cytochromes P450 CYP619 involved in biosynthesis of patulin in Aspergillus clavatus. Microbiology 2009, 155:1738-1747.
18. Ehlting J., Sauveplane V., Olry A., Ginglinger J.-F., Provart N., Werck-Reichhart D. An extensive (co-)expression analysis tool for the cytochrome P450 superfamily in Arabidopsis thaliana. BMC Plant Biol 2008, 8:47.
19. Kruse T., Ho K., Yoo H.-D., Johnson T., Hippely M., Park J.-H., Flavell R., Bobzin S. In planta biocatalysis screen of P450s identifies 8-methoxypsoralen as a substrate for the CYP82C subfamily, yielding original chemical structures. Chem Biol 2008, 15:149-156.
20. Sauveplane V., Kandel S., Kastner P.E., Ehlting J., Compagnon V., Werck-Reichhart D., Pinot F. Arabidopsis thaliana CYP77A4 is the first cytochrome P450 able to catalyze the epoxidation of free fatty acids in plants. FEBS J 2009, 276:719-735.
21. Dobritsa A.A., Shrestha J., Morant M., Pinot F., Matsuno M., Swanson R., Moller B.L., Preuss D. CYP704B1 is a long-chain fatty acid ω-hydroxylase essential for sporopollenin synthesis in pollen of Arabidopsis. Plant Physiol 2009, 151:574-589.
22. Fu C., Xiong J., Miao W. Genome-wide identification and characterization of cytochrome P450 monooxygenase genes in the ciliate Tetrahymena thermophila. BMC Genomics 2009, 10:208.
23. Kulas J., Schmidt C., Rothe M., Schunck W.-H., Menzel R. Cytochrome P450-dependent metabolism of eicosapentaenoic acid in the nematode Caenorhabditis elegans. Arch Biochem Biophys 2008, 472:65-75.
24. Lamb D.C., Lei L., Warrilow A.G.S., Lepesheva G.I., Mullins J.G.L., Waterman M.R., Kelly S.L. The first virally encoded cytochrome P450. J Virol 2009, 83:8266-8269.
25. Schroer K., Kittelman M., Lütz S. Recombinant human cytochrome P450 monooxygenases for drug metabolite synthesis. Biotechnol Bioeng 2010, 106:699-706.
26. Weis R., Winkler M., Schittmayer M., Kambourakis S., Vink M., Rozzell J.D., Glieder A. A diversified library of bacterial and fungal bifunctional cytochrome P450 enzymes for drug metabolite synthesis. Adv Synth Catal 2009, 351:2140-2146.
27. Johnston W.A., Weiliang H., De Voss J.J., Hayes M.A., Gillam E.M.J. Quantitative whole-cell cytochrome P450 measurement suitable for high-throughput application. J Biomol Screen 2008, 13:135-141.
28. Furuya T., Nishi T., Shibata D., Suzuki H., Ohta D., Kino K. Characterization of orphan monooxygenases by rapid substrate screening using FT-ICR mass spectrometry. Chem Biol 2008, 15:563-572.
29. Chen Y., Tang W.L., Mou J., Li Z. High-throughput method for determining the enantioselectivity of enzyme-catalyzed hydroxylations based on mass spectrometry. Angew Chem Int Ed 2010, 49:5278-5283.
30. Rabe K.S., Spengler M., Erkelenz M., Müller J., Gandubert V.J., Hayen H., Niemeyer C.M. Screening for cytochrome P450 reactivity by harnessing catalase as reporter enzyme. ChemBioChem 2009, 10:751-757.
31. Virus C., Bernhardt R. Molecular evolution of a steroid hydroxylating cytochrome P450 using a versatile steroid detection system for screening. Lipids 2008, 43:1133-1141.
32. Sukumaran S.M., Potsaid B., Lee M.-Y., Clark D.S., Dordick J.S. Development of a fluorescence-based, ultra high-throughput screening platform for nanoliter-scale cytochrome P450 microarrays. J Biomol Screen 2009, 14:668-678.
33. Bailo E., Fruk L., Niemeyer C., Deckert V. Surface-enhanced Raman scattering as a tool to probe cytochrome P450-catalysed substrate oxidation. Anal Bioanal Chem 2009, 394:1797-1801.
34. BM3 (CYP102A1). ChemBioChem 2009, 10:1654-1656.
35. Dietrich M., Do T.A., Schmid R.D., Pleiss J., Urlacher V.B. Altering the regioselectivity of the subterminal fatty acid hydroxylase P450 BM-3 towards [gamma]- and [delta]-positions. J Biotechnol 2009, 139:115-117.
36. Chen C.-K., Shokhireva T., Berry R., Zhang H., Walker F. The effect of mutation of F87 on the properties of CYP102A1-CYP4C7 chimeras: altered regiospecificity and substrate selectivity. J Biol Inorg Chem 2008, 13:813-824.
37. Damsten M.C., van Vugt-Lussenburg B.M.A., Zeldenthuis T., de Vlieger J.S.B., Commandeur J.N.M., Vermeulen N.P.E. Application of drug metabolising mutants of cytochrome P450 BM3 (CYP102A1) as biocatalysts for the generation of reactive metabolites. Chemico-Biol Interact 2008, 171:96-107.
38. Seifert A., Vomund S., Grohmann K., Kriening S., Urlacher V.B., Luschat S., Pleiss J. Rational design of a minimal and highly enriched CYP102A1 mutant library with improved regio-, stereo- and chemoselectivity. ChemBioChem 2009, 10:853-861.
39. Dietrich J.A., Yoshikuni Y., Fisher K.J., Woolard F.X., Ockey D., McPhee D.J., Renninger N.S., Chang M.C.Y., Baker D., Keasling J.D. A novel semi-biosynthetic route for artemisinin production using engineered substrate-promiscuous P450BM3. ACS Chem Biol 2009, 4:261-267.
40. Ryan J.D., Fish R.H., Clark D.S. Engineering cytochrome P450 enzymes for improved activity towards biomimetic 1,4-NADH cofactors. ChemBioChem 2008, 9:2579-2582.
41. Rosic N.N. Versatile capacity of shuffled cytochrome P450s for dye production. Appl Microbiol Biotechnol 2009, 82:203-210.
42. Lewis J.C., Arnold F.H. Catalysts on demand: selective oxidations by laboratory-evolved cytochrome P450 BM3. Chimia 2009, 63:309-312.
43. BM3) variants oxidise a range of non-natural substrates and offer new selectivity options. Chem Commun 2008, 966-968.
44. Sawayama A.M., Chen M.M.Y., Kulanthaivel P., Kuo M.-S., Hemmerle H., Arnold F.H. A panel of cytochrome P450 BM3 variants to produce drug metabolites and diversify lead compounds. Chem Eur J 2009, 15:11723-11729.
45. Rentmeister A., Arnold F.H., Fasan R. Chemo-enzymatic fluorination of unactivated organic compounds. Nat Chem Biol 2009, 5:26-28.
46. Lewis J.C., Bastian S., Bennett C.S., Fu Y., Mitsuda Y., Chen M.M., Greenberg W.A., Wong C.-H., Arnold F.H. Chemoenzymatic elaboration of monosaccharides using engineered cytochrome P450BM3 demethylases. Proc Natl Acad Sci 2009, 106:16550-16555.
47. Li H.-M., Mei L.-H., Urlacher V., Schmid R. Cytochrome P450 BM-3 evolved by random and saturation mutagenesis as an effective indole-hydroxylating catalyst. Appl Biochem Biotechnol 2008, 144:27-36.
48. Liu L., Schmid R., Urlacher V. Engineering cytochrome P450 monooxygenase CYP 116B3 for high dealkylation activity. Biotechnol Lett 2010, 32:841-845.
49. Kabumoto H., Miyazaki K., Arisawa A. Directed evolution of the actinomycete cytochrome P450 MoxA (CYP105) for enhanced activity. Biosci Biotechnol Biochem 2009, 73:1922-1927.
50. Fujii Y., Kabumoto H., Nishimura K., Fujii T., Yanai S., Takeda K., Tamura N., Arisawa A., Tamura T. Purification, characterization, and directed evolution study of a vitamin D3 hydroxylase from Pseudonocardia autotrophica. Biochem Biophys Res Commun 2009, 385:170-175.
51. Li S., Chaulagain M.R., Knauff A.R., Podust L.M., Montgomery J., Sherman D.H. Selective oxidation of carbolide C-H bonds by an engineered macrolide P450 mono-oxygenase. Proc Natl Acad Sci 2009, 106:18463-18468.
52. Robin A., Roberts G.A., Kisch J., Sabbadin F., Grogan G., Bruce N., Turner N.J., Flitsch S.L. Engineering and improvement of the efficiency of a chimeric [P450cam-RhFRed reductase domain] enzyme. Chem Commun 2009, 2478-2480.
53. Sabbadin F., Hyde R., Robin A., Hilgarth E.-M., Delenne M., Flitsch S., Turner N., Grogan G., Bruce N.C. LICRED: a versatile drop-in vector for rapid generation of redox-self-sufficient cytochrome P450s. ChemBioChem 2010, 11:987-994.
54. Hirakawa H., Nagamune T. Molecular assembly of P450 with ferredoxin and ferredoxin reductase by fusion to PCNA. ChemBioChem 2010, 11:1517-1520.
55. Zhou Y., Minami T., Honda K., Omasa T., Ohtake H. Systematic screening of Escherichia coli single-gene knockout mutants for improving recombinant whole-cell biocatalysts. Appl Microbiol Biotechnol 2010, 87:647-655.
56. Zehentgruber D., Hannemann F., Bleif S., Bernhardt R., Lütz S. Towards preparative scale steroid hydroxylation with cytochrome P450 monooxygenase CYP106A2. ChemBioChem 2010, 11:713-721.
57. Ryan J.D., Clark D.S. P450cam biocatalysis in surfactant-stabilized two-phase emulsions. Biotechnol Bioeng 2008, 99:1311-1319.
58. Tee K.L., Roccatano D., Stolte S., Arning J., Jastorff B., Schwaneberg U. Ionic liquid effects in the activity of monooxygenase P450 BM-3. Green Chem 2008, 10:117-123.